Agilent Technologies, Inc. (A)
$
116.98
+0.29 (0.25%)
Key metrics
Financial statements
Free cash flow per share
4.9439
Market cap
33.9 Billion
Price to sales ratio
5.1919
Debt to equity
0.5580
Current ratio
2.1974
Income quality
1.3479
Average inventory
984.5 Million
ROE
0.2095
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Agilent Technologies, Inc. provides application-focused solutions to life sciences, diagnostics, and applied chemical markets globally. The Life Sciences and Applied Markets segment delivers a wide array of analytical instruments and systems, including liquid chromatography systems and components, mass spectrometry systems, gas chromatography systems, and various spectroscopy technologies. The company's innovative approach is evident in its diverse offerings such as cell analysis plate-based assays, flow cytometers, laboratory automation tools, and dissolution testing equipment. Additionally, Agilent incurred an interest expense of $96,000,000.00 reflecting its debt servicing obligations. The gross profit ratio is 0.54 which highlights the efficiency of the company's production and sales operations. Furthermore, the diluted EPS is $4.43 accounting for potential share dilution, while the net income ratio stands at 0.20 demonstrating the company's profitability margin. The reported depreciation and amortization expenses amount to $0.00 underscoring the wear and tear of its assets. On the diagnostics front, Agilent offers advanced technologies for DNA analysis, including arrays for mutation detection and next-generation sequencing, along with reagents for turbidimetry. In addition, Agilent CrossLab segment delivers essential laboratory supplies and services such as custom chemistries and sample preparation products. The stock is reasonably priced at $116.06 appealing to a broad range of investors. With a high average trading volume of 1,886,403.00 there is strong liquidity in the stock, making it an attractive option for market participants. The company showcases a mid-range market capitalization of $33,351,348,940.00 positioning it as a steady performer within the sector. As a key player in the Medical - Diagnostics & Research industry, Agilent significantly contributes to the overall market landscape, driving innovation and growth within the Healthcare sector. Its comprehensive range of products is marketed through direct sales, distributors, and electronic commerce, ensuring a broad reach in delivering its advanced solutions to a global clientele.
What is Agilent Technologies, Inc. (A)'s stock forecast?
Analysts predict Agilent Technologies, Inc. stock to fluctuate between $113.76 (low) and $155.35 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Agilent Technologies, Inc.'s market capitalization?
As of 2025-04-01, Agilent Technologies, Inc.'s market cap is $33,351,348,940, based on 285,103,000 outstanding shares.
How does Agilent Technologies, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Agilent Technologies, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Agilent Technologies, Inc. (A) stock?
To buy Agilent Technologies, Inc. (A) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for A. Place an order (Market, Limit, etc.).
What is the best time to invest in Agilent Technologies, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did Agilent Technologies, Inc. perform in the last earnings report?
Revenue: $6,510,000,000 | EPS: $4.44 | Growth: 5.21%.
Where can I find Agilent Technologies, Inc.'s investor relations reports?
Visit https://www.agilent.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Agilent Technologies, Inc.?
You can explore historical data from here
What is the all-time high and low for Agilent Technologies, Inc. stock?
All-time high: $179.57 (2021-09-03) | All-time low: $96.80 (2023-10-30).
What are the key trends affecting Agilent Technologies, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
businesswire.com
SANTA CLARA, Calif.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions to the fifth paragraph. The updated release reads: AGILENT TO SHOWCASE NEXT-GENERATION DIGITAL PATHOLOGY SOLUTIONS AT USCAP 2025 Agilent Technologies Inc. (NYSE: A) is excited to announce its participation at the upcoming United States and Canadian Academy of Pathology (USCAP) Conference, which will be held March 22-27, 2025, in Boston. At the conference, Agilent will.
seekingalpha.com
Agilent Technologies, a leader in life sciences and diagnostics, has a market cap of $38B and a 10-year CAGR of 13.6%. Key financial metrics: consistent revenue growth, stable gross profit margin above 50%, and a robust return on invested capital, despite some fluctuations. The stock fell too far after its recent earnings report, making it too good to pass up at its current level.
businesswire.com
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell — along with CFO Bob McMahon — will participate in a fireside chat at TD Cowen's 45th Annual Health Care Conference at 9:50-10:20 a.m. Eastern on Tuesday, March 4, 2025, in Boston, Massachusetts. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a globa.
seekingalpha.com
Agilent Technologies, Inc. (NYSE:A ) Q1 2025 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Parmeet Ahuja - Vice President of Investor Relations Padraig McDonnell - President and Chief Executive Officer Robert W. McMahon - Senior Vice President and Chief Financial Officer Simon May - President of Life Sciences and Diagnostics Markets Group Angelica Riemann - President of Agilent CrossLab Group Mike Zhang - President of Applied Markets Group Conference Call Participants Rachel Vatnsdal - J.P.
zacks.com
Agilent Technologies (A) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.29 per share a year ago.
reuters.com
Medical equipment maker Agilent lowered its annual revenue forecast on Wednesday, as it expects soft demand for its medical tools and equipment from smaller biotech companies.
zacks.com
A's fiscal first-quarter performance is likely to have been influenced by higher expenses, increased CapEx and the Lunar New Year timing shift.
businesswire.com
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2025 after the stock market closes on Wednesday, Feb. 26. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PST. To join the listen-only conference call webcast, click the link on the Events section of Agilent's investor relations website. A recording of the call also will be available on the website for 90 days. Abo.
businesswire.com
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that it will feature new automated laboratory workflow solutions at the SLAS2025 International Conference & Exhibition being held January 25-29, at the San Diego Convention Center in California. Agilent is a leader in advancing automation solutions to help customers optimize lab performance, efficiency, and reproducibility across their entire pipeline, from research and drug discovery to development an.
zacks.com
A faces challenges with slowing end-market demand and regulatory hurdles in China, raising growth concerns.
See all news
